Posted 1 year ago

A Study Evaluating the Efficacy and Safety of Pirtobrutinib in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

ClinicalTrials.gov ID NCT06588478

Protocol number J2N-MC-JZNX

Sponsor Loxo Oncology, Inc.